Universitaetsklinikum Bonn AöR
Universitaetsklinikum Bonn AöR is recorded as a service provider in 12 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 12 of 12 trials · Latest update first
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of Methotrexate as Remission Maintenance Therapy after Remission-Induction Therapy with Tocilizumab and Glucocorticoids in Subjects with Giant Cell Arteritis
Sponsor Not reported
- Start (EU)
- Latest update
- Estimated end
- Not reported
Operational learnings available2 trial-level findings · Read insights
- The observed 12-month relapse rate was lower than expected, with 14/52 participants (26.9%) experiencing a relapse.
- The trial was conducted at a single German center, which may limit generalizability.
These findings describe the trial, not the service provider’s performance or responsibility.
FINISHER – Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage
Sponsor Not reported
- Start (EU)
- Latest update
- Estimated end
- Not reported
Operational learnings available2 trial-level findings · Read insights
- The trial was conducted exclusively at German centers, which may limit generalizability.
- Modified Rankin Scale assessment could not be blinded to patients’ clinical trajectory despite concealed treatment allocation, and missing outcome data required imputation.
These findings describe the trial, not the service provider’s performance or responsibility.
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
Sponsor GPOH gGmbH
- Start (EU)
- Latest update
- Estimated end
A double-blinded, randomized, placebo-controlled, multi-center trial of Efgartigimod in autoimmune dementia (EfgaDem)
Sponsor Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V.
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
Sponsor The University Of Birmingham
- Start (EU)
- Latest update
- Estimated end
Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma
Sponsor GPOH gGmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
B-cell depletion for the treatment of patients with amyotrophic lateral sclerosis (ALS) - A Randomized, Double-blind, Placebo controlled Pilot Study in Patients with Amyotrophic Lateral Sclerosis for the Evaluation of Efficacy and Safety of B-Cell Depletion with Rituximab (ABCD)
Sponsor Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients - NB2015-LR
Sponsor University Of Cologne
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
MucPreDex: Radiation-induced MUCositis PREvention using DEXpanthenol mouth rinse
Sponsor Rheinische Friedrich-Wilhelms-Universitaet Bonn
- Start (EU)
- Latest update
- Estimated end
- Not reported
Proof of concept study (multicenter, phase II) on the efficacy of the selective TYK2 inhibitor Deucravacitinib in Lichen planus patients (DEUCRALIP)
Sponsor Rheinische Friedrich Wilhelms Universitaet Bonn
- Start (EU)
- Latest update
- Estimated end
- Not reported
MOdern Treatment of Inhibitor-PositiVe PATiEnts with Haemophilia A – An International Low-Interventional Pragmatic Investigator Initiated Trial
Sponsor HZRM Haemophilie-Zentrum Rhein Main GmbH
- Start (EU)
- Latest update
- Estimated end
Microdosing with a serotonergic agent for ADHD and emotion regulation: biological factors explaining and predicting treatment response
Sponsor Universiteit Maastricht
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Universitaetsklinikum Bonn AöR?
The 2026-10-09 snapshot links Universitaetsklinikum Bonn AöR to 12 distinct CTIS trials. Recorded services include Statistical analysis, Clinical monitoring, Safety reporting & pharmacovigilance, Data management, among 17 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Universitaetsklinikum Bonn AöR?
The most frequently recorded therapeutic areas are Immunology, Neurology, Solid Tumor Oncology, Otolaryngology. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Universitaetsklinikum Bonn AöR conducted?
The linked trials record locations in 17 countries, including Germany, Finland, Sweden, Austria, Belgium. These are trial locations, not confirmed office locations or countries where Universitaetsklinikum Bonn AöR delivered services.
What can this page tell me about Universitaetsklinikum Bonn AöR's trial experience?
Browse 12 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 2 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Universitaetsklinikum Bonn AöR. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Universitaetsklinikum Bonn AöR